Ľubomíra Fábryová

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens et al. · The Lancet · 2023 · 71 citations · Full text

Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes

Alena Viktorínová, Ingrid Jurkovičová, Ľubomíra Fábryová et al. · Diabetes Research and Clinical Practice · 2018 · 34 citations

Metabolic Syndrome, Biochemistry, Apolipoprotein A1 +11

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

Martin Wawruch, Gejza Wimmer, Ján Murín et al. · Drugs & Aging · 2019 · 18 citations

Older Patients, Aging, Cardiovascular Epidemiology +13

Familial defective apolipoprotein B-100 in Slovakia

Juraj Gašparovič, Zuzana Bašistová, Ľubomíra Fábryová et al. · Atherosclerosis · 2006 · 17 citations

Genetic Disorder, Genetics, Genetic Epidemiology +6